LCSG - formerly LCS Golf (fka LCSG)

[jmhollen]

LCS Golf, Inc. Enters Into a Letter of Intent to Acquire T-19 Inc.

WEST PALM BEACH, Fla., Feb 20, 2002 (BW HealthWire) -- LCS Golf (OTCBB:LCSG) announced today that it has entered into a Letter of Intent agreement to acquire at least 90% of the outstanding privately held shares of T-19 Incorporated based in Honolulu, Hawaii, in an all stock transaction.

At the completion of the acquisition, T-19 shareholders will own the majority of LCS GOLF INC.

T-19 Incorporated holds the worldwide distribution rights for T-19. (http://www.T-19.com) T-19 is a Nasal Spray comprised of a natural compound called Tubercin, which enjoys US and other foreign patents. The T-19 Nasal Spray will be marketed worldwide through traditional retail distribution networks as a holistic treatment. T-19 may enhance the human immune system and help improve overall health. T-19 (http://www.Tubercin.com) is natural and has no known adverse side effects.

Dr. Ronald Shinn President and CEO of T-19 incorporated comments, "We are delighted with LCS Golf and Dr. Michael Mitchell for furthering our capabilities with their expertise and resources to help bring T-19 to the market."

CONTACT: T-19 Incorporated, Honolulu Eric Schopfer, 866/523-5800

.